CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 88 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-06 | Hirth Peter Director | Grant or award | +1,550 | 7,175 | ||
| 2024-06-06 | Hirth Peter Director | Grant or award · Stock Option (right to buy) | +7,250 | 7,250 | ||
| 2023-06-13 | Hirth Peter Director | Grant or award | +2,500 | 5,625 | ||
| 2023-06-13 | Hirth Peter Director | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2022-06-01 | Hirth Peter Director | Grant or award | +3,125 | 3,125 | ||
| 2022-06-01 | Hirth Peter Director | Grant or award · Stock Option (right to buy) | +18,750 | 18,750 |
Page 1 of 1 · 6 trades